FDA 483 - Johnson Memorial Cancer Center - October 21, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Johnson Memorial Cancer Center in Enfield, CT, a producer of sterile drug products, revealed critical deficiencies in aseptic processing. Observations included inadequate cleaning of work surfaces for hazardous drugs, failure to disinfect materials before entering aseptic areas, and deficient air pattern analyses for ISO 5 classified areas. Additionally, non-sterile disinfecting agents were used in critical aseptic processing environments, indicating a high risk of contamination.
ID · 2e0a2b75-d595-4113-bae7-510918d002d2